In 2000, NIH began funding a program called the Protein Structure Initiative, or PSI. PSI has been controversial since its creation was first discussed, and as I contemplate PSI today I find myself humming the fine old Gershwin tune, ''Lets Call the Whole Thing Off.'' PSI remains the bad idea it always was, and I am not alone in regarding it so (Petsko, 2007) . However, given the number of people both inside and outside NIH who have a stake in its continuation, PSI is unlikely to go away anytime soon, and those foolish enough to argue for its abolition are liable to find themselves losing friends while failing to influence people.
The PSI is a large, centralized program focused on protein structure determination that not only emulates the Human Genome Project, but was stimulated by it. By the late 1990s, in no small measure because of the success of the Human Genome Project, protein sequences began accumulating in databases far faster than protein structures could be solved. Furthermore, the labor, cost, and uncertainties connected with protein structure determination being what they were-and still are-it seemed unlikely the structural biology community would ever ''catch up''. Consequently, some began arguing that an enterprise similar in scale to the Human Genome Project should be launched to industrialize the determination of protein structures. If this were done, the argument went, the sequence-structure ''gap'' would quickly close, and the impact on medicine and biology would rival that of the Human Genome Project. NIH responded by establishing the Protein Structure Initiative (PSI), and today, as the second cycle of PSI grants are being awarded, NIH supports 10 centers at a cost of about $60,000,000 a year. Enthusiasm for structural genomics is not limited to the United States; similar centers exist in other countries.
The long-term objective of PSI is, ''.to make the three-dimensional structures of most proteins easily obtainable from knowledge of their corresponding DNA sequences'' (http://www.nigms.nih/gov/Initiatives/ PSI/Background/MissionStatement. htm). Implicit in this objective is the notion that we do not need to solve the structure of every single protein on the planet experimentally, a Sisyphean task if there ever was one. The proponents of PSI point out that the number of different tertiary folds found in protein domains is many orders of magnitude smaller than the number of different protein domains, as determined by sequence, which is true. They then argue that if high resolution structures were obtained for protein domains representing every fold class it would then be possible to compute the structure of all other protein domains whose sequences are known by homology modeling. Thus if PSI were to produce the requisite catalog of domain structures using the high-throughput experimental structure determination methods it develops, computational biochemists would take care of the rest, and untold amounts of time and effort would be saved. Unfortunately, at the present time, there is no evidence that that protein models accurate enough to be useful biochemically can be derived from sequences by homology modeling or by any other computational means.
In thinking about the rationale for PSI, it is useful to ask who wants/needs high resolution protein structures in the first place, because not everyone does. Thousands of cell and molecular biologists take the view that once all the macromolecules involved in some process have been identified and one-line descriptions obtained for their functions, you know all you need to know. They feel that way for reason; a lot of biology can be understood at that level. Only the minority that needs/wants to understand the chemistry responsible for the properties of macromolecules finds atomic resolution macromolecular structures essential. (NB: It does not follow that high resolution structures lack value! On the contrary, much that is of the greatest importance for both public health and for biology can be obtained from high resolution structures.)
It also important to ask whether computation of protein structures from protein sequences by homology modeling is a realistic goal, even if it does not happen to be feasible today. In the end, all macromolecular structures are models, and it is already possible to compute three-dimensional models for macromolecules starting from their sequences. The problem with these models is that they are neither useful nor reliable. In order for a molecular model to be fully useful in a chemical sense, it must specify the positions of individual nonhydrogen atoms with errors on the order of, say, 0.5 Å´or less, and a reliable model is one in whose accuracy its users can trust. In my book, only models that are useful and reliable deserve to be called ''structures,'' and I have yet to be shown a nontrivial protein model computed from sequence alone that qualifies. To put it another way, if your laboratory were to begin an investigation that depended on your knowledge of a protein's structure and all you had was a structural model for it computed from its sequence, wouldn't you begin by determining its structure experimentally? I submit that you would be crazy if you did not.
In fact, all the useful, reliable models for macromolecules we have today, i.e., all macromolecular structures, have been obtained by techniques that, however they work, end up by finding that fold of a macromolecule's sequence which is most consistent both with a large body of experimental data that has been obtained about that particular macromolecule either by crystallography or by NMR, and with what is known about the geometry of organic molecules more generally. (For the record, most of what we know about molecular bond lengths and angles also comes from crystallography.) The consistency of these structures with experimental data validates them, and because they have been validated this way (on the whole) they can be relied upon.
There are profound physical reasons why computational approaches to the protein folding problem have thus far yielded so little solid information about the specific details of protein structures. No matter whether an initial model for a protein is obtained by homology modeling or not, it must be refined to optimize the placement of residues, and this is done by energy minimization techniques. The force fields commonly used to find lowest energy conformations of macromolecules assume that interatomic interactions are pair-wise additive, which simply untrue. In condensed phases, polarization phenomena strongly influence molecular behavior and polarization energies, which include van der Waals interactions, are not pair-wise additive (Maitland et al., 1981) . But even if this notoriously difficult problem in physical chemistry was solved, which it may be at some point, the way forward would still be unclear. How do you estimate the accuracy of a protein structure arrived at by computation? How do you validate a computed model for a protein's structure short of determining its structure experimentally, and if you are prepared to do that, why bother computing its structure? Thus there are reasons for doubting that PSI will ever bring us to the paradise in which one needs only the sequence of a protein to determine its structure. Hello, Sisyphus!
There are other problems with PSI. It is remarkable how little you know about a protein if all you have is its three-dimensional structure. It is bound to be a mixture of a helices and b sheets in some combination, and they usually pack together to make a dense, amorphous blob. In fact, if you have seen a few protein ribbon diagrams you have seen them all, and I say this as someone who still remembers the excitement he felt as a graduate student in the early 1960s when he attended a series of lectures on the crystal structure of hemoglobin given at Harvard University by Max Perutz. The fact is that protein structures come alive intellectually only when they are connected with genetic, and/or biochemical, and/or physiological data indicating what they do and hinting at how they might do it. Thus the solving of the structures of proteins of unknown function simply because their sequences suggest they might have novel folds, which is a major focus PSI activity, is a misguided activity. Far better to concentrate on the structures of proteins whose functional significance is already clear.
In this regard it is interesting that NIH has lately begun asking PSI centers to devote a fraction of their efforts to solving specific structures in response to requests made by members of the wider biological community (http:// www.nigms.nih.gov/News/Reports/psi2_ update_052007.htm). This was not part of the original plan! This change in direction suggests that over time PSI centers may morph into protein structure solving centers that behave a lot like the DNA sequencing and synthesis centers on which we all depend. This would be a sorry outcome indeed compared to what was originally promised.
The $60,000,000 a year NIH is spending on PSI would pay for a lot of single-investigator RO1 grants. The rate at which new physiological processes are being uncovered by cell and molecular biologists today is stunning, and there are lots of young structural biologists eager to work on them. NIH would get a lot more for its money if it used its PSI funds to support single investigators who use either X-ray crystallography or NMR to understand how macromolecules of known biological significance work. Those asking NIH to fund this kind of research would have to justify their activities not by the number of new entries they promised to add to structural databases, but instead by the biological impact of the work they propose. Thus the biological community would be assured that each new structure it ''paid for'' fit into a functional context that was of known biological significance. NIH would reap an additional benefit by making this change. Single investigator, problem-driven laboratories are much better places to train graduate students and postdoctoral students than factories that churn out a single kind of data.
The NIH would also be wise to invest some of its PSI money in the activities of physical chemists interested in the properties of condensed phase matter. A lot of the best members of that community do not think about biology from one year's end to the next, but they are the people most likely to solve the fundamental force field problems referred to above.
Interestingly, even though research on force fields might pay dividends, as far as one can tell, there is little research of this sort going on in PSI centers. Instead the staffs at these centers are working to increase the speed with which protein structures can be determined experimentally, and solving as many new protein structures as possible, as fast as possible, with preference being given to proteins that by sequence appear likely to belong to novel fold classes. There are also efforts underway to perfect the art of homology modeling, which could be helpful, but is unlikely to be decisive by itself for the reasons just discussed.
If PSI is allowed to carry on, a lot of new protein structures will get deposited in the protein databases, which is a good thing, even if we have no idea what the physiological relevance
